Physician profile
Usman Barlass
NPI 1720469042
$8,228.94
in general payments reported to CMS, 2019-2025
9 companies · $2,770 in 2025
The $2,770 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.12 · 2021: $25.73 · 2022: $880 · 2023: $1,642 · 2024: $2,876 · 2025: $2,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,302 · Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,301.65 |
| Food and Beverage | $985.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $6,341.22 | 2023-2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Boston Scientific Corporation | $814.89 | 2020-2025 | Overstitch Nxt Endoscopic Suturing System, Overstitch Endoscopic Suturing System, Spyglass |
| Apollo Endosurgery US INC | $802.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $124.84 | 2024 | Entyvio |
| Olympus America INC. | $53.48 | 2022 | |
| Abbvie INC. | $31.96 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.49 | 2022 | |
| Janssen Biotech, INC. | $22.00 | 2025 | Tremfya |
| Cook Medical LLC | $14.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Barlass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.